Does my Medicare Plan cover Wegovy or Zepbound in 2024?
The Medicare Prescription Drug, Improvement, And Modernization Act Of 2003 directs that Medicare Part D (outpatient) plans cannot cover drugs used for weight loss. It is notable though that obesity screening, behavioral counseling and bariatric surgery are covered. So, in the strictest sense, you will not be able to obtain coverage from your Part D plan for drugs like Wegovy (semaglutide, Novo Nordisk) or Zepbound (tirzepatide, Eli Lilly).
Wegovy to be made available under Medicare Part D plans
The weight loss injectable drug Wegovy (semaglutide) received FDA (Food and Drug Administration) approval in March 2024 for a supplemental cardiovascular indication. This has huge implications for health plans operating Medicare Part D programs. It now means patients who meet weight and major cardiovascular risk criteria can obtain coverage for Wegovy. Since Zepbound does not have a supplemental cardiovascular FDA approved indication, it cannot be covered.
Therefore, if you have Medicare Part D outpatient coverage and you are overweight or obese and have pre-existing (severe) cardiovascular disease, then you may be covered under your plan. But remember, because Wegovy is not designated as one of the six protected drug classes, the plans do not have to include Wegovy into its formulary of reimbursable drugs.
This means that plans are most likely to take a cautious approach to approvals and require prior authorizations, especially because Wegovy is extremely expensive, with a list price of around $16,200 for a one-year supply.
Medicaid coverage or Zepbound & Wegovy
Medicaid can cover weight loss drugs, however, only 20% of state Medicaid agencies currently provide this coverage. You should check with your state Medicaid program to see if they offer Zepbound or Wegovy coverage.
Since Wegovy has received its supplemental FDA indication, all Medicaid agencies will now be obligated to place it on their lists of reimbursable drugs. However, they can still require patients to follow step edits (trying cheaper alternatives first) before they can obtain Wegovy for the cardiovascular indication.
Sources
What is NowPatient
Online Pharmacy & Telehealth
NowPatient is an online pharmacy & telehealth service that is available in the US and UK. Our service is FREE and packed with useful features that can help you save money on the cost of your medications, access virtual treatments, and provide tools that can help improve your overall health. Get started today and benefit from medication reminders, private treatment plans, NHS online pharmacy, GP appointment booking, Rx savings card, Drug Coupons, US drug savings programs, health conditions information, Drug Information, genetic testing, home test kits, BMI Risks, Type 2 Diabetes Risks, pollen meter, air quality monitor, and lots more!
WHY WE BUILT NOWPATIENT
To improve the lives of everyone by making high-quality care accessible and convenient
We are here to improve lives. Our service gives you access to smart features and resources that can help empower you to take control of your health and improve your health outcomes. All this, in one place, for FREE. We strive to bring a fresh perspective to managing health. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Can I trust NowPatient
Meet our medical team
We are a passionate group of clinicians and medical writers covering a broad range of specialities with experience operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process